BioRender 아이콘

Cancer cell (apoptosis, blebbing)

Cancer cell (apoptosis, blebbing) - Editable icon of an irregular-shaped cancer cell that is blebbing and going through apoptosis
[{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843eae/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843eae/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843ead/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843ead/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843eac/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843eac/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843eab/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843eab/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843eaa/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843eaa/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843ea9/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843ea9/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843ea8/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843ea8/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843ea7/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843ea7/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843ea6/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843ea6/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843ea5/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843ea5/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843ea4/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843ea4/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843ea3/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843ea3/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843ea2/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843ea2/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843ea1/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843ea1/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843ea0/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843ea0/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e9f/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e9f/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e9e/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e9e/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e9d/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e9d/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e9c/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e9c/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e9b/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e9b/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e9a/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e9a/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e99/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e99/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e98/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e98/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e97/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e97/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e96/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e96/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e95/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e95/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e94/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e94/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e93/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e93/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e92/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e92/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e91/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e91/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e90/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e90/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e8f/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e8f/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e8e/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e8e/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e8d/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e8d/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e8c/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e8c/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e8b/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e8b/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e8a/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e8a/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e89/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e89/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e88/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e88/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e87/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e87/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e86/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e86/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e85/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e85/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e84/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e84/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e83/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e83/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e82/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e82/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e81/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e81/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e80/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e80/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e7f/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e7f/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e7e/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e7e/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e7d/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e7d/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e7c/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e7c/61537531e75ac20029699fdb.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6176ffaeaa87c30029843e7b/61537531e75ac20029699fdb.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6176ffaeaa87c30029843e7b/61537531e75ac20029699fdb.png"}]
이 아이콘 사용하기 – 무료
가입 시 신용카드가 필요하지 않습니다.

이 아이콘은 BioRender에서 자유롭게 편집할 수 있습니다

  • 텍스트, 도형 및 기타 아이콘 추가
  • 5만 개 이상의 과학적으로 정확한 아이콘을 검색하세요
  • 모든 아이콘, 선, 라벨의 색상과 배치를 자유롭게 변경하세요
  • 어떤 용도로든 내보내거나 공유하세요
Scientist Avatars

이미 출판용 수준의 그림을 만들고 있는 400만 명 이상의 과학자들과 함께하세요

아이콘으로 몇 분 만에 완성된 그림을 만들어 보세요

  • 검색 50,000개 이상의 과학적으로 정확하고 동료 검토를 거친 아이콘 제공
  • 맞춤 설정 라벨, 도형, 추가 아이콘을 사용하여 모든 요소를 자유롭게 편집할 수 있습니다.
  • 내보내기 또는 공동 작업자와 그림 공유하기
    ‍

찾으시는 아이콘이 아닌가요? 더 많은 아이콘을 확인해 보세요.

30개 이상의 생명과학 분야에 걸친 50,000개 이상의 아이콘을 검색하세요.

search icon
arrow-right
cancer,cancer cell,tumor cell,tumour cell,cell,apoptosis,apoptosing,bleb,blebbing,cell death,dying,dead,die,programmed cell death,fragment,fragmented,fragmenting,oncology,carcinoma,leukaemia,leukemia,lymphoma,sarcoma,mesothelioma,myeloma,metastasis,moving,relocating,internalcellupdate-high-impact-21q3 ,cell,cancer cell,tumor cell,tumour cell
더 보기

동의어를 검색하거나 가입하여 앱에서 아이콘을 요청해 보세요.

이미지 유형

Cancer cell (apoptosis, blebbing) icon JPEG

Cancer cell (apoptosis, blebbing) icon PNG

Cancer cell (apoptosis, blebbing) icon SVG

Cancer cell (apoptosis, blebbing) icon GIF

BioRender 아이콘 FAQ

How are scientists using the Cancer cell (apoptosis, blebbing) icon in their work?

BioRender users often use the Cancer cell (apoptosis, blebbing) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.

이 아이콘을 BioRender 그림이나 과학 일러스트레이션에 사용할 수 있나요?

Yes, the Cancer cell (apoptosis, blebbing) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Cancer cell (apoptosis, blebbing) icon customizable in BioRender?

Most icons in BioRender, including the Cancer cell (apoptosis, blebbing) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Cancer cell (apoptosis, blebbing) icon for publication or presentations?

Yes, figures containing the Cancer cell (apoptosis, blebbing) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Cancer cell (apoptosis, blebbing) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Cancer cell (apoptosis, blebbing) icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

BioRender란 무엇인가요?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Cancer cell (apoptosis, blebbing) icon along with our library of more than 30,000 life science icons.

BioRender에서 이 아이콘 사용하기

지금 바로 전문가 수준의 과학 피규어를 만들어 보세요
antibody elements3D Phospholipid illustration

과학 콘텐츠를 찾고 계신가요?

동료 검토를 거쳐 사용하기 쉽고 무료로 제공되는 5만 개 이상의 아이콘과 템플릿을 살펴보세요.

지금 바로 찾아보세요
x icon